Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A Traditional Chinese Medicine (TCM) periodic therapy developed by the Children's Hospital of Fudan University for treating adolescent dysfunctional uterine bleeding (DUB) associated with Yin deficiency and blood heat syndrome. The treatment follows a two-phase protocol: during the bleeding period, a kidney-tonifying hemostasis prescription (comprising Nvzhenzi, Hanliancao, Tusizi, Xianhecao, Cebaiyetan, Danpi, and Zhimu) is administered to stop bleeding by clearing heat and consolidating the Chong and Ren channels. In the post-bleeding phase, a kidney-tonifying and menstruation-regulating prescription (comprising Shengshudi, Zhimu, Tusizi, Fupenzi, Bajirou, Danggui, and Danpi) is used to strengthen essence and regulate the menstrual cycle. The therapy is administered as oral granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine.